MedPath

GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes

Phase 3
Completed
Conditions
Obesity
Type 2 Diabetes
Registration Number
NCT00398060
Lead Sponsor
Finnish Institute for Health and Welfare
Brief Summary

Life-style change achieved in controlled experimental condition has been shown to prevent type 2 diabetes. The purpose of this study is to evaluate to what extent the life-style change can be achieved in a routine health care setting.

Detailed Description

The GOAL (Good Ageing in Lahti region) Program Life-style change implementation trial to prevent type 2 diabetes was set to examine and enhance the effectiveness of life-style change counselling in the primary health care. In the intervention, specific nutritional, physical activity and weight loss objectives shown effective in diabetes prevention in an earlier randomised controlled trial are used as a benchmark, embedded in a structured group counselling model with an empowerment-oriented approach and adapted into the primary health care setting. In the trial, effectiveness and process are evaluated, the analyses including gender and socio-economic differences. Participants were 361 middle-aged (50-65 yrs) adults at an increased risk for type 2 diabetes, recruited in 16 primary health care centres in Paijat-Hame, Finland. Intervention and data collection took place in year 2003.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
389
Inclusion Criteria
  • Type 2 diabetes risk test score > 11 (Lindstrom & Tuomilehto, 2003)
Exclusion Criteria
  • mental health problem or substance abuse likely to interfere with participation
  • acute cancer
  • type 2 diabetes requiring pharmacological treatment
  • myocardial infarction during the past six months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Nutrition (fat, fiber)0-1 years
Physical activity0-3 years
Weight0-3 years
Secondary Outcome Measures
NameTimeMethod
Waist circumference0-3 years
Plasma glucose (fasting, 2 hr challenge)0-3 years
Serum lipids0-3 years
Blood pressure (diastolic, systolic)0-3 years

Trial Locations

Locations (1)

Päijät-Häme Hospital District

🇫🇮

Lahti, Finland

Päijät-Häme Hospital District
🇫🇮Lahti, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.